benzylaminopurine has been researched along with Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drabsch, Y; Gao, R; Huang, H; Lu, CX; Mickanin, C; Porter, JA; Sheppard, KA; Snaar-Jagalska, BE; ten Dijke, P; Zhang, L; Zhou, F | 1 |
1 other study(ies) available for benzylaminopurine and Breast Cancer
| Article | Year |
|---|---|
USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor.
Topics: Animals; Breast Neoplasms; Cell Membrane; Cell Movement; Enzyme Stability; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation; HEK293 Cells; HeLa Cells; Humans; Mice; Mice, Knockout; Mutation; Neoplasm Invasiveness; Oncogene Proteins; Phosphorylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; RNA Interference; Signal Transduction; Time Factors; Transfection; Transforming Growth Factor beta; Ubiquitin Thiolesterase; Ubiquitin-Specific Proteases; Ubiquitination; Zebrafish | 2012 |